Non-adherence without borders: Cross continent perspectives and local realities
The importance of medication adherence in cardiovascular disease management is highlighted in this session with the presentation of a health economic study conducted in three middle-income countries: Mexico, Thailand, and China1.
Prof. Arintaya Phrommintikul highlights the clinical consequences of non-adherence and emphasizes recommendations for better risk factor control. Prof. Nathorn Chaiyakunapruk delves into the study, demonstrating the positive impact of improved adherence, with significant reductions in cardiovascular events and healthcare costs. Dr. Miguel Diaz calls for integrating adherence into health policies and explores innovative technological solutions.
Watch the video to learn more about the perspectives of clinicians, economists, and policymakers on the clinical and economic benefits of improving adherence.
1. Cho JY, et al. Projected Cost Savings with Optimal Medication Adherence in Cardiovascular Disease Patients Requiring Lipid Lowering Therapy: a Multi-National Economic Evaluation Study. JAHA 2024. Manuscript in Press.
Speakers
Prof. Arintaya
Phrommintikul
Thailand
Prof. Nathorn
Chaiyakunapruk
United States
Dr. Miguel Angel
Díaz Aguilera
Mexico
